Maximum daily dose of G-CSF is critical for preventing recurrence of febrile neutropenia in patients with gynecologic cancer: A case–control study

No study has evaluated the effect of therapeutic granulocyte colony-stimulating factor (G-CSF) in preventing recurrence of febrile neutropenia (FN) and survival outcomes in gynecologic cancer patients. Objective of this study is to optimize and to identify the use of G-CSF and identify the critical...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Nam Kyeong, Suh, Dong Hoon, Kim, Kidong, No, Jae Hong, Kim, Yong Beom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410604/
https://www.ncbi.nlm.nih.gov/pubmed/36042607
http://dx.doi.org/10.1097/MD.0000000000030155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410604/
https://www.ncbi.nlm.nih.gov/pubmed/36042607
http://dx.doi.org/10.1097/MD.0000000000030155

Ejemplares similares